Jain Vandana, Kar Dharmesh, Natarajan S, Shome Debraj, Mehta Hitendra, Mehta Hijab, Jayadev Chaitra, Borse Nishikant
Department of Cornea and External Diseases, Aditya Jyot Eye Hospital Pvt. Ltd, Wadala, Mumbai, India.
Indian J Ophthalmol. 2007 May-Jun;55(3):203-6. doi: 10.4103/0301-4738.31941.
To describe the results of a combined procedure including phacoemulsification, insertion of posterior chamber intraocular lens (PCIOL) and pars plana vitrectomy (PPV) in eyes with vitreoretinal pathology and coexisting significant cataract.
Retrospective, consecutive, noncomparative, interventional case series.
Medical records of patients who had undergone phacoemulsification, PPV and PCIOL implantation as a combined procedure between January 2000 and December 2004 were retrospectively reviewed. The main outcome measures were the anatomical success of retina, defined as reattached retina, intraoperative and postoperative complications and functional success in terms of final best corrected visual acuity.
In all, 65 eyes of 64 patients were included. The mean age of the patients was 50.9 years +/- 17.1 (range, five to 82 years). Vitreous hemorrhage with or without retinal detachment (19 eyes, 29.2%) was the most common indication for the vitreoretinal procedure. Primary anatomical success of retina was achieved in 59 eyes (90.7%). Visual acuity improved in 48 eyes (73.8%), was unchanged in 12 eyes (18.5%) and deteriorated in five eyes (7.7%). Postoperative inflammation was significantly more in the subgroup of previously vitrectomized eyes (42%) (P =0.014, Fisher exact test) compared to those which underwent primary vitrectomy.
Combined surgery is a feasible option for patients with vitreoretinal diseases and cataract.
描述在患有玻璃体视网膜病变并伴有明显白内障的眼中,进行包括超声乳化白内障吸除术、后房型人工晶状体(PCIOL)植入术和平坦部玻璃体切除术(PPV)的联合手术的结果。
回顾性、连续性、非对照性、干预性病例系列。
回顾性分析2000年1月至2004年12月期间接受超声乳化白内障吸除术、PPV和PCIOL植入联合手术的患者的病历。主要观察指标为视网膜的解剖学成功,定义为视网膜复位、术中及术后并发症以及最终最佳矫正视力方面的功能成功。
共纳入64例患者的65只眼。患者的平均年龄为50.9岁±17.1岁(范围为5至82岁)。伴有或不伴有视网膜脱离的玻璃体积血(19只眼,29.2%)是玻璃体视网膜手术最常见的适应证。59只眼(90.7%)实现了视网膜的初次解剖学成功。48只眼(73.8%)视力提高,12只眼(18.5%)视力不变,5只眼(7.7%)视力下降。与接受初次玻璃体切除术的患者相比,既往接受过玻璃体切除术的亚组术后炎症明显更多(42%)(P = 0.014,Fisher确切概率检验)。
联合手术对于患有玻璃体视网膜疾病和白内障的患者是一种可行的选择。